{"id":"W4386945206","doi":"10.1080/13543776.2023.2262136","title":"Type I inhibitors of tropomyosin receptor kinase (Trk): a 2020–2022 patent update","year":2023,"lang":"en","type":"review","venue":"Expert Opinion on Therapeutic Patents","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"TRIUMF; University of British Columbia; University of Alberta","funders":"","keywords":"Trk receptor; Medicine; Precision medicine; Pharmacology; Bioinformatics; Cancer research; Computational biology; Biology; Receptor; Internal medicine; Neurotrophin; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063615,0.0007681282,0.0008214962,0.002226264,0.0002321483,0.001185876,0.0007996141,0.001178011,0.01927953],"category_scores_gemma":[0.0009696619,0.0001888788,0.0009245661,0.002103102,0.0002469648,0.001332467,0.0005223958,0.001542787,0.005962405],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007864243,"about_ca_system_score_gemma":0.001367206,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001045403,"about_ca_topic_score_gemma":0.002417961,"domain_scores_codex":[0.999765,0.00003210016,0.00002238451,0.00002837877,0.0001126819,0.00003947219],"domain_scores_gemma":[0.9996408,0.000123768,0.00007165685,0.000007797941,0.0001180266,0.00003801401],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001046767,0.00005895813,0.0000868586,0.01075042,0.00006032508,0.0002972566,0.0000353184,0.0002576337,0.001812406,0.003612386,0.1327875,0.8501363],"study_design_scores_gemma":[0.00003005964,0.00007166399,0.0002928907,0.002422625,0.00008287181,0.0005264697,0.00001413942,0.00005673074,0.000244209,0.0007993088,0.9954516,0.000007425489],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0007086503,0.97809,0.0004653363,0.003003828,0.00201637,0.00005547027,0.0004323235,0.0000653207,0.01516256],"genre_scores_gemma":[0.002731744,0.9869006,0.000452769,0.001964651,0.0008878051,0.00003709484,0.0004929149,0.000009665645,0.006522722],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01927953,"threshold_uncertainty_score":0.06449646,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1103937892736046,"score_gpt":0.3584458892396905,"score_spread":0.2480520999660859,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}